These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36154582)

  • 1. The Selective NLRP3-Inflammasome Inhibitor CY-09 Ameliorates Kidney Injury in Diabetic Nephropathy by Inhibiting NLRP3- inflammasome Activation.
    Yang M; Zhao L
    Curr Med Chem; 2023; 30(28):3261-3270. PubMed ID: 36154582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.
    Wang S; Li Y; Fan J; Zhang X; Luan J; Bian Q; Ding T; Wang Y; Wang Z; Song P; Cui D; Mei X; Ju D
    Cell Death Dis; 2017 Jul; 8(7):e2937. PubMed ID: 28726774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Song W; Wei L; Du Y; Wang Y; Jiang S
    Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.
    Ren C; Bao X; Lu X; Du W; Wang X; Wei J; Li L; Li X; Lin X; Zhang Q; Ma B
    Phytomedicine; 2022 Sep; 104():154310. PubMed ID: 35843189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irbesartan ameliorates diabetic nephropathy by activating the Nrf2/Keap1 pathway and suppressing NLRP3 inflammasomes in vivo and in vitro.
    Li Y; Long W; Zhang H; Zhao M; Gao M; Guo W; Yu L
    Int Immunopharmacol; 2024 Apr; 131():111844. PubMed ID: 38503013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys.
    Hou Y; Wang Q; Han B; Chen Y; Qiao X; Wang L
    Cell Death Dis; 2021 May; 12(6):523. PubMed ID: 34021126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerobic exercise training alleviates renal injury in db/db mice through inhibiting Nox4-mediated NLRP3 inflammasome activation.
    Zhou Z; Ying C; Zhou X; Shi Y; Xu J; Zhu Y; Wang M; Li Y; Li X; Xiang J
    Exp Gerontol; 2022 Oct; 168():111934. PubMed ID: 36007721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dioscorea zingiberensis ameliorates diabetic nephropathy by inhibiting NLRP3 inflammasome and curbing the expression of p66Shc in high-fat diet/streptozotocin-induced diabetic mice.
    Ren C; Zhou X; Bao X; Zhang J; Tang J; Zhu Z; Zhang N; Bai Y; Xi Y; Zhang Q; Ma B
    J Pharm Pharmacol; 2021 Aug; 73(9):1218-1229. PubMed ID: 34061184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV ameliorates diabetic nephropathy in
    Feng H; Zhu X; Tang Y; Fu S; Kong B; Liu X
    Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the NLRP3 Inflammasome in Diabetic Nephropathy.
    Yang M; Wang X; Han Y; Li C; Wei L; Yang J; Chen W; Zhu X; Sun L
    Curr Med Chem; 2021; 28(42):8810-8824. PubMed ID: 34225600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
    Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
    J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.
    Chen K; Feng L; Hu W; Chen J; Wang X; Wang L; He Y
    FASEB J; 2019 Mar; 33(3):4571-4585. PubMed ID: 30571313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
    Lv C; Cheng T; Zhang B; Sun K; Lu K
    Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
    [No Abstract]   [Full Text] [Related]  

  • 15. ChREBP Deficiency Suppresses Renal Inflammation and Fibrosis Via Inhibiting NLRP3 Inflammasome Activation in Diabetic Kidney Disease.
    Chen N; Yang Z; Mu L; Wu M; Song J; Zhou T; Shi Y
    Discov Med; 2022; 33(169):69-83. PubMed ID: 36274225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.
    Du L; Wang J; Chen Y; Li X; Wang L; Li Y; Jin X; Gu X; Hao M; Zhu X; Yin X; Lu Q
    Cell Biol Toxicol; 2020 Jun; 36(3):243-260. PubMed ID: 31768838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome.
    Wang B; Dai Z; Gao Q; Liu Y; Gu G; Zheng H
    Biochem Biophys Res Commun; 2022 Feb; 594():131-138. PubMed ID: 35081502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome.
    Ding H; Li J; Li Y; Yang M; Nie S; Zhou M; Zhou Z; Yang X; Liu Y; Hou FF
    Mol Ther; 2021 Jul; 29(7):2308-2320. PubMed ID: 33744467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice.
    Yu Y; Chen D; Zhao Y; Zhu J; Dong X
    Int J Immunopathol Pharmacol; 2021; 35():20587384211036819. PubMed ID: 34399601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificially Cultivated
    Wang C; Hou XX; Rui HL; Li LJ; Zhao J; Yang M; Sun LJ; Dong HR; Cheng H; Chen YP
    J Diabetes Res; 2018; 2018():1390418. PubMed ID: 30534570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.